The result of this retrospective analysis shows that hybrid closed‐loop users with well‐controlled Type 1 diabetes have higher bolusing frequency and total amount of self‐administered bolus insulin relative to total daytime insulin, compared with those with suboptimally controlled diabetes. The gene discussed is INS; the disease is diabetes mellitus.